Primary Sclerosing Cholangitis Market Is Driven By Increasing Drug Approvals
The primary sclerosing cholangitis (PSC) market overview comprises growing prevalence of autoimmune and inflammatory liver diseases globally. Primary sclerosing cholangitis is a chronic condition that causes progressive inflammation and scarring of bile ducts in the liver. Some key symptoms include fatigue, jaundice and itching. Current treatment involves management of symptoms,...
0 Comments 0 Shares 468 Views
Sponsored